ITRM20060584A1 - Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni - Google Patents
Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuniInfo
- Publication number
- ITRM20060584A1 ITRM20060584A1 IT000584A ITRM20060584A ITRM20060584A1 IT RM20060584 A1 ITRM20060584 A1 IT RM20060584A1 IT 000584 A IT000584 A IT 000584A IT RM20060584 A ITRM20060584 A IT RM20060584A IT RM20060584 A1 ITRM20060584 A1 IT RM20060584A1
- Authority
- IT
- Italy
- Prior art keywords
- timoxine
- alfa
- medication
- care
- prevention
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000584A ITRM20060584A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
| EP07827728A EP2086569A2 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| AU2007310416A AU2007310416A1 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| JP2009534061A JP2010507650A (ja) | 2006-10-27 | 2007-09-27 | 自己免疫疾患の予防及び治療用の薬剤を調製するためのチモシンアルファ1の使用 |
| EA200900602A EA200900602A1 (ru) | 2006-10-27 | 2007-09-27 | Применение альфа 1-тимозина для приготовления лекарства для профилактики и лечения аутоиммунных заболеваний |
| CNA200780040140XA CN101534853A (zh) | 2006-10-27 | 2007-09-27 | 胸腺素α-1用于制备预防及治疗自身免疫性疾病的药物 |
| US12/446,670 US20100004174A1 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| BRPI0718010-1A BRPI0718010A2 (pt) | 2006-10-27 | 2007-09-27 | Uso da timosina alfa 1 para preparação de um medicamento para a prevenção e tratamento de doenças autoimunes. |
| MX2009004196A MX2009004196A (es) | 2006-10-27 | 2007-09-27 | Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de enfermedades autoinmunes. |
| PCT/IT2007/000677 WO2008050363A2 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| KR1020097007708A KR20090096688A (ko) | 2006-10-27 | 2007-09-27 | 자가면역 질환의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도 |
| CA002666609A CA2666609A1 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| IL198291A IL198291A0 (en) | 2006-10-27 | 2009-04-22 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000584A ITRM20060584A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITRM20060584A1 true ITRM20060584A1 (it) | 2008-04-28 |
Family
ID=39322489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000584A ITRM20060584A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100004174A1 (enExample) |
| EP (1) | EP2086569A2 (enExample) |
| JP (1) | JP2010507650A (enExample) |
| KR (1) | KR20090096688A (enExample) |
| CN (1) | CN101534853A (enExample) |
| AU (1) | AU2007310416A1 (enExample) |
| BR (1) | BRPI0718010A2 (enExample) |
| CA (1) | CA2666609A1 (enExample) |
| EA (1) | EA200900602A1 (enExample) |
| IL (1) | IL198291A0 (enExample) |
| IT (1) | ITRM20060584A1 (enExample) |
| MX (1) | MX2009004196A (enExample) |
| WO (1) | WO2008050363A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100248272A1 (en) * | 2009-03-31 | 2010-09-30 | Cornell University | Method for identifying Smk box riboswitch modulating compounds |
| WO2025078961A1 (en) * | 2023-10-13 | 2025-04-17 | Gufic Biosciences Limited | Composition and method for treatment of endometriosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5852225A (ja) * | 1981-09-22 | 1983-03-28 | Mitsui Pharmaceut Inc | 脱髄疾患治療剤 |
| US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
| TW249754B (enExample) * | 1993-10-26 | 1995-06-21 | Alpha I Biomedicals Inc | |
| US5888980A (en) * | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
| CA2270223A1 (en) * | 1996-10-28 | 1998-05-07 | Carson B. Burgstiner (Deceased) | Methods and compositions for dietary supplementation |
| CN1198950A (zh) * | 1998-04-24 | 1998-11-18 | 崔泊 | 一种结肠炎新药的制备 |
| CN1628796A (zh) * | 2004-08-20 | 2005-06-22 | 康合堂 | 一种治疗溃疡性结肠炎的药物 |
-
2006
- 2006-10-27 IT IT000584A patent/ITRM20060584A1/it unknown
-
2007
- 2007-09-27 JP JP2009534061A patent/JP2010507650A/ja active Pending
- 2007-09-27 BR BRPI0718010-1A patent/BRPI0718010A2/pt not_active IP Right Cessation
- 2007-09-27 CN CNA200780040140XA patent/CN101534853A/zh active Pending
- 2007-09-27 WO PCT/IT2007/000677 patent/WO2008050363A2/en not_active Ceased
- 2007-09-27 MX MX2009004196A patent/MX2009004196A/es not_active Application Discontinuation
- 2007-09-27 AU AU2007310416A patent/AU2007310416A1/en not_active Abandoned
- 2007-09-27 EA EA200900602A patent/EA200900602A1/ru unknown
- 2007-09-27 EP EP07827728A patent/EP2086569A2/en not_active Withdrawn
- 2007-09-27 CA CA002666609A patent/CA2666609A1/en not_active Abandoned
- 2007-09-27 KR KR1020097007708A patent/KR20090096688A/ko not_active Withdrawn
- 2007-09-27 US US12/446,670 patent/US20100004174A1/en not_active Abandoned
-
2009
- 2009-04-22 IL IL198291A patent/IL198291A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008050363A8 (en) | 2009-06-04 |
| WO2008050363A2 (en) | 2008-05-02 |
| MX2009004196A (es) | 2009-06-30 |
| WO2008050363A3 (en) | 2008-06-26 |
| CA2666609A1 (en) | 2008-05-02 |
| CN101534853A (zh) | 2009-09-16 |
| JP2010507650A (ja) | 2010-03-11 |
| EA200900602A1 (ru) | 2009-10-30 |
| IL198291A0 (en) | 2011-08-01 |
| BRPI0718010A2 (pt) | 2013-11-19 |
| EP2086569A2 (en) | 2009-08-12 |
| US20100004174A1 (en) | 2010-01-07 |
| KR20090096688A (ko) | 2009-09-14 |
| AU2007310416A1 (en) | 2008-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182105A0 (en) | Use of memantine for the preparation of a medicament for the treatment of childhood behavioral disorders | |
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| EP1789075A4 (en) | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION | |
| EP2391419A4 (en) | ACTIVE INFUSION IN THE REAR EYE SEGMENT | |
| PL2878297T3 (pl) | Leki do leczenia lub zapobiegania chorobom zwłóknieniowym | |
| DK1957110T3 (da) | Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed | |
| EP2192855A4 (en) | MODELING A PATIENT RECOVERY | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
| EP2027849A4 (en) | External preparation for skin | |
| EP2098240A4 (en) | MEDIUM TO PROMOTE THE HEALING OF A LIVING BODY | |
| TWI366457B (en) | Use of a beta2-adrenoceptor agonist for the preparation of a dermatological medicament | |
| IL187632A (en) | 17 – Ethinyl – 17 – Hydroxy – 13 – Methyl – 17,16,15,14,13,12,11,9,8,7 – Dachahydro – 6 h– Cyclopentane [a] Penanthran – 3 – Ilmethyl ester of acetoxy acid Acetic, a pharmaceutical dosage unit containing it and its use in the preparation of a contraceptive | |
| ITRM20060584A1 (it) | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni | |
| BRPI0720089A2 (pt) | Uso de l-carnitina para a preparação de um medicamento na forma de colírio para o tratamento de doenças da córnea | |
| EP1714648A4 (en) | COMBINATION DRUGS | |
| ITMI20021866A1 (it) | Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee. | |
| ITRM20060583A1 (it) | Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie | |
| ITRM20040288A1 (it) | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. | |
| UA9011S (uk) | Упаковка фармацевтичного засобу «кетозорал» | |
| UA10191S (uk) | Етикетка медичного препарату «ксилат» | |
| UA13071S (uk) | Упаковка фармацевтичного препарату «повадин» | |
| IT1396649B1 (it) | Preparazioni farmaceutiche comprendenti floroglucinolo e/o suoi derivati e farmaci anti-infiammatori non steroidi e loro uso nel trattamento e/o nella prevenzione delle sindromi dolorose dell'apparato genitale femminile. | |
| UA9934S (uk) | Гігієнічний засіб для догляду за порожниною рота | |
| UA9547S (uk) | Упаковка фармацевтичного засобу «урсохол» | |
| UA10726S (uk) | Комплект упаковок для фармацевтичного препарату «дермазол» |